846 related articles for article (PubMed ID: 29610017)
21. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
[TBL] [Abstract][Full Text] [Related]
22. Effect of narrow-band UVB phototherapy on soluble cell adhesion molecules in patients with psoriasis vulgaris.
Long JW; Tao J; Pi XM; Wang YY; Tu YT
J Int Med Res; 2010; 38(4):1507-12. PubMed ID: 20926025
[TBL] [Abstract][Full Text] [Related]
23. Role of Lymphocyte Subpopulations in The Immunopathogenesis of Psoriasis and The Effect of Narrow Band UVB Phototherapy on The Immunological Profile of Psoriasis Patients.
Fattouh M; El-Din AN; El-Hamd MA
Egypt J Immunol; 2017 Jan; 24(1):105-117. PubMed ID: 29120583
[TBL] [Abstract][Full Text] [Related]
24. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
25. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
[TBL] [Abstract][Full Text] [Related]
26. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
[TBL] [Abstract][Full Text] [Related]
27. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
28. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
[No Abstract] [Full Text] [Related]
29. The influence of psoriatic plaques pretreatment with crude coal tar vs. petrolatum on the efficacy of narrow-band ultraviolet B: a half-vs.-half intra-individual double-blinded comparative study.
Abdallah MA; El-Khateeb EA; Abdel-Rahman SH
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):226-30. PubMed ID: 21950625
[TBL] [Abstract][Full Text] [Related]
30. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
[TBL] [Abstract][Full Text] [Related]
31. Concentration of selenium, zinc, copper, Cu/Zn ratio, total antioxidant status and c-reactive protein in the serum of patients with psoriasis treated by narrow-band ultraviolet B phototherapy: A case-control study.
Wacewicz M; Socha K; Soroczyńska J; Niczyporuk M; Aleksiejczuk P; Ostrowska J; Borawska MH
J Trace Elem Med Biol; 2017 Dec; 44():109-114. PubMed ID: 28965564
[TBL] [Abstract][Full Text] [Related]
32. Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity.
Montero-Vilchez T; Segura-Fernández-Nogueras MV; Pérez-Rodríguez I; Soler-Gongora M; Martinez-Lopez A; Fernández-González A; Molina-Leyva A; Arias-Santiago S
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477944
[TBL] [Abstract][Full Text] [Related]
33. Catechol-O-methyltransferase activity is higher in psoriasis patients and is down-regulated by narrowband ultraviolet B treatment.
Magina S; Moura E; Serrão MP; Moura D; Vieira-Coelho MA
Eur J Dermatol; 2013; 23(1):49-52. PubMed ID: 23399536
[TBL] [Abstract][Full Text] [Related]
34. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.
Lynch M; Malara A; Timoney I; Vencken S; Ahern T; Awdeh F; Sweeney C; Galligan M; Kelly G; Hughes R; Murad A; Hambly R; O'Shea D; Doran P; Kirby B
Dermatology; 2022; 238(1):140-147. PubMed ID: 33866313
[TBL] [Abstract][Full Text] [Related]
35. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Ortonne JP; Khemis A; Koo JY; Choi J
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of UV-based therapy for psoriasis.
Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
[TBL] [Abstract][Full Text] [Related]
37. Epidermal changes during UVB phototherapy assessed by multiphoton laser tomography.
Koehler MJ; Kellner K; Kaatz M; Hipler UC
Skin Res Technol; 2016 Nov; 22(4):437-442. PubMed ID: 26853735
[TBL] [Abstract][Full Text] [Related]
38. Effect of narrow-band ultraviolet B phototherapy on p63 and microRNA (miR-21 and miR-125b) expression in psoriatic epidermis.
Gu X; Nylander E; Coates PJ; Nylander K
Acta Derm Venereol; 2011 Jun; 91(4):392-7. PubMed ID: 21373745
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B.
Farshchian M; Ansar A; Sobhan M; Hoseinpoor V
An Bras Dermatol; 2016; 91(5):580-583. PubMed ID: 27828628
[TBL] [Abstract][Full Text] [Related]
40. Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes.
Rácz E; Prens EP; Kant M; Florencia E; Jaspers NG; Laman JD; de Ridder D; van der Fits L
Br J Dermatol; 2011 Apr; 164(4):838-47. PubMed ID: 21143460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
